News
Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...
3d
Live Science on MSN2-in-1 COVID-flu vaccine looks promising, but approval could be delayedLate-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...
Since bird flu was first discovered in U.S. cattle last year, the virus has spread to more than 1,000 herds across the ...
Pigs could play a key role in ending the flu as we know it. That’s the message behind new research testing a ...
University of Pennsylvania researchers have discovered a right-handed, antiparallel double-helix inside influenza ...
Proposed changes to the vaccine approval process violate ethical and scientific principles.
The announcement, which followed the FDA setting new guidelines on COVID vaccine approvals, erased the stock’s gains from ...
The university’s Center for Vaccine Development is recruiting people for a study into pre-existing flu immunity in healthy adults.
Moderna has withdrawn its pending application for a combination vaccine for both the flu and Covid-19, saying it will resubmit later this year once it has more data.
The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results